Chemoinformaics analysis of Hepta-3,5-dien-2-one
| Molecular Weight | 110.156 | nRot | 2 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 3 |
| Exact Molecular Weight | 110.073 | nRing | 0 |
| Solubility: LogS | -1.155 | nHRing | 0 |
| Solubility: LogP | 1.347 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 19.1599 |
| nHD | 0 | BPOL | 10.9001 |
| QED | 0.39 |
| Synth | 2.937 |
| Natural Product Likeliness | 1.692 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.337 |
| MDCK | 0.0000318 |
| BBB | 0.945 |
| PPB | 0.722642 |
| VDSS | 1.229 |
| FU | 0.279515 |
| CYP1A2-inh | 0.261 |
| CYP1A2-sub | 0.424 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.84 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.321 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.8 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.327 |
| CL | 5.857 |
| T12 | 0.797 |
| hERG | 0.021 |
| Ames | 0.797 |
| ROA | 0.917 |
| SkinSen | 0.969 |
| Carcinogencity | 0.737 |
| EI | 0.99 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.051 |
| Antiviral | No |
| Prediction | 0.950251 |